Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

GLP-1s - which mimic the effects of the hormone that stimulates insulin release, suppressing glucagon, and slowing gastric emptying - also have a range of other benefits.

The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However, he ...

In a new study, one nutrient made a difference in muscle loss for people losing weight on drugs like Ozempic. Here's what to eat to preserve your muscle on the meds.

Poor-quality or unregulated caviar also carries a risk of heavy metal or pollutant contamination; however, Gentry notes that ...

New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI ...

Bariatric surgeon Jonathan Carter discusses the pros and cons of surgery compared with GLP-1 drugs. For those with severe ...

Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...

I am a 75-year-old woman who isn’t prediabetic or diabetic. My BMI is 31.2. My doctor has prescribed a trial of metformin for ...

Novo Nordisk NVO shares have plunged 19.9% year to date, following a string of unfavorable outcomes, both pipeline and ...

Results from this study show that there is a direct correlation between the use of anti-obesity medications and testosterone levels,” the study author said.